Posts by Timothy Wilens, MD
Treatment for Substance Use Disorder Reduces Risk of Overdose in Young Adults
In young adults, the most significant predictors of overdose after treatment for substance use disorder are a history of intravenous drug use and mood dysregulation—and the first year after the initial evaluation is the riskiest period. However, engagement in treatment has been found to reduce this risk.
Practice Changes to Reduce Misuse of Prescription Medications
Research on misuse of prescription medications has revealed simple practice changes that can have a big impact on the health of young patients.
Translation, Discovery and Collaboration in Psychiatry
Researchers from the Department of Psychiatry at Massachusetts General Hospital discuss their collaborative work in clinical and translational research.
Exposure to Maternal Substance Use Disorder Increases Risk of Alcohol Use Disorder in Young Adults
In the largest study of its kind, psychiatrists at Massachusetts General Hospital have presented evidence that, independent of ADHD status, young adults who lived with a mother who had a substance use disorder are at increased risk of developing the disorder themselves.
Misuse of Prescription Stimulants in Young Adults
In this video, Timothy Wilens, MD, chief of Massachusetts General Hospital's Division of Child and Adolescent Psychiatry and co-director of the Center for Addiction Medicine, discusses his research into the misuse and diversion of stimulant medications in young people.
Youth with Substance Use Disorders Should Be Screened for Overdose Risk Factors
Psychiatrists at Massachusetts General Hospital have uncovered risk factors for nonfatal drug overdose among young adults being treated for substance use disorder.
Dr. Timothy Wilens is chief, Division of Child and Adolescent Psychiatry and co-director, Center for Addiction Medicine at Mass General. He is also an associate professor of psychiatry at Harvard Medical School in Boston, Massachusetts. Dr. Wilens earned his BS in literature, science and arts at the University of Michigan Honors College and his MD at the University of Michigan Medical School in Ann Arbor. His residency in child, adolescent, adult and addiction psychiatry was completed at Massachusetts General Hospital under the auspices of Harvard Medical School in Boston.
Dr. Wilens' research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; and the pharmacotherapy of ADHD and juvenile bipolar disorder across the lifespan. His peer-reviewed articles concerning these and related topics number more than 275, and are published in prestigious journals such as the American Journal of Psychiatry, Archives of General Psychiatry, and Pediatrics. Dr. Wilens has also published more than 80book chapters, and 300 abstracts and presentations for national and international scientific meetings.
Dr. Wilens is a Distinguished Fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry, serves as a scientific reviewer for 25journals, and is active in a number of other local and national professional societies. Dr. Wilens is named consistently among "The Best of Boston" in Child/Adult Psychiatry and "The Best Doctors in America."